Table 1.

Demographic, baseline comorbidities and clinical characteristics at admission of patients with COVID-19, and differences between patients who survived and dead. COPD: chronic obstructive pulmonary disease.

	Overall (n = 322)	Dead (n = 75)	Discharged (n = 247)	p
Mean age at admission, years (SD; rank)	68.4 (15.2; 1–99)	76.5 (11.1; 47–99)	65.9 (15.4; 1–96)	<0.001
Sex
Male, n (%)	164 (50.9%)	43 (57.3%)	121 (49%)	0.205
Female; n (%)	158 (49.1%)	32 (42.7%)	126 (51%)
Smoker
No; n (%)	138 (61.1%)	27 (46.6%)	111 (66.1%)	0.019
Yes; n (%)	19 (8.4%)	5 (8.6%)	14 (8.3%)
Former; n (%)	69 (30.5%)	26 (44.8%)	43 (25.6%)
No data; n (%)	96 (29.8%)	17 (22.7%)	79 (32%)	–
Arterial hypertension; n (%)	194 (60.2%)	60 (80%)	134 (54.3%)	<0.001
Dyslipidemia; n (%)	107 (33.2%)	32 (42.7%)	75 (30.4%)	0.048
Diabetes; n (%)	102 (31.7%)	29 (38.7%)	73 (29.6%)	0.137
Obesity; n (%)	63 (19.6%)	16 (21.3%)	47 (19%)	0.659
COPD; n (%)	30 (9.3%)	10 (13.3%)	20 (8.1%)	0.172
Asthma; n (%)	17 (5.3%)	3 (4%)	14 (5.7%)	0.771
Cerebrovascular accident; n (%)	19 (5.9%)	8 (10.7%)	11 (4.5%)	0.048
Ischemic heart disease; n (%)	35 (10.9%)	14 (18.7%)	21 (8.5%)	0.013
Venous thromboembolic disease; n (%)	14 (4.3%)	4 (5.3%)	10 (4%)	0.746
Cognitive impairment; n (%)	30 (9.3%)	12 (16%)	18 (7.3%)	0.023
Peripheral vascular disease; n (%)	10 (3.1%)	1 (1.3%)	9 (3.6%)	0.312
Chronic kidney disease; n (%)	28 (8.7%)	9 (12%)	19 (7.7%)	0.246
Autoimmune disease; n (%)	15 (4.7%)	2 (2.7%)	13 (5.3%)	0.543
Solid tumor; n (%)	41 (12.7%)	15 (20%)	26 (10.5%)	0.031
Leukemia; n (%)	7 (2.2%)	3 (4%)	4 (1.6%)	0.360
Symptoms
Cough; n (%)	193 (59.9%)	45 (60%)	148 (59.9%)	0.990
Fever; n (%)	199 (61.8%)	50 (66.7%)	149 (60.3%)	0.322
Dyspnea; n (%)	205 (63.7%)	61 (81.3%)	144 (58.3%)	<0.001
Chest pain; n (%)	22 (6.8%)	5 (6.7%)	17 (6.9%)	0.948
Ageusia; n (%)	11 (3.4%)	2 (2.7%)	9 (3.6%)	0.999
Anosmia; n (%)	11 (3.4%)	0	11 (4.5%)	0.074
Diarrhea; n (%)	41 (12.7%)	8 (10.7%)	33 (13.4%)	0.540
Vomiting; n (%)	20 (6.2%)	6 (8%)	14 (5.7%)	0.426
Syncope; n (%)	6 (1.9%)	1 (1.35)	5 (2%)	0.999